JP1302 Chemische Eigenschaften,Einsatz,Produktion Methoden

Biologische Aktivit?t

α 2C -adrenoceptor antagonist that displays ~ 50-fold selectivity over other α 2 -adrenoceptor subtypes (K i values are 28, 1470, 1700 and 3150 nM for human α 2C , α 2B , α 2D and α 2A subtypes respectively). Potently antagonizes adrenalin-stimulated 35 GTP γ S binding in vitro (K B = 16 nM) and produces antidepressant and antipsychotic-like effects in vivo .

JP1302 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

JP1302 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32466	58
Aladdin Scientific		tp@aladdinsci.com	United States	52923	58
DAYANG CHEM (HANGZHOU) CO.,LTD	+86-88938639 +86-17705817739	info@dycnchem.com	China	53803	58
3B Pharmachem (Wuhan) International Co.,Ltd.	18930552037	3bsc@sina.com	China	15838	69
VDM Biochemicals	0330-2528181	sales@vdmbio.com	United States	510	64
Shanghai Lollane Biological Technology Co.,Ltd.	021-52996696，15000506266 15000506266		China	4849	55
Shanghaizehan biopharma technology co., Ltd.	021-61350663 13052117465	sales@zehanbiopharma.com	China	977	55
EMMX Biotechnology LLC	888-539-0666	info@emmx.com	United States	8447	60
Shanghai YuanYe Biotechnology Co., Ltd.	13636370518	shyysw007@163.com	China	89686	60
Tianjin Kailiqi Biotechnology Co., Ltd.	15076683720	klq@cw-bio.com	China	9689	55

---

• JP1302
• 9-Acridinamine, N-(4-(4-methyl-1-piperazinyl)phenyl)-
• Brn 5117597
• N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine
• JP 1302 dihydrochloride
• N-[4-(4-Methyl-1-piperazinyl)phenyl]-9-acridinaminedihydrochloride
• JP1302(9-Acridinamine, N-[4-(4-methyl-1-piperazinyl)phenyl]-)
• MMV006172
• N-(4-(4-Methylpiperazin-1-yl)phenyl)acridin-9-amine
• 80259-18-3
• C24H24N42HCl
• Potently antagonizes adrenalin-stimulated 35GTPγS binding in vitro (KB = 16 nM) and produces antidepressant and antipsychotic-like effects in vivo.